780G system approved in T2D in USA

The FDA has approved Medtronic’s MiniMed 780G automated insulin delivery (AID) system for use in Type 2 diabetes. At the same time, FDA also cleared the MiniMed SmartGuard algorithm as an “interoperable automated glycemic controller,” which enables integration with a new sensor called Instinct for Type 1 diabetes. The Instinct, made by Abbott specifically for use with MiniMed AID and smart pen products, is smaller than currently marketed sensors and lasts up to 15 days.

The MiniMed 780G system is available for people with Type 1 diabetes aged 7 years or older and for adults aged 18 years or older with insulin-requiring Type 2 diabetes, with the company’s Guardian 4 sensor and the Simplera Sync sensor.

Medtronic and Abbott are working to finalize the regulatory process so that the Instinct sensor can be ordered with the MiniMed 780 for T1D first. After that, Medtronic will submit an application for the use of the MiniMed 780G integration with the Instinct for T2D.

To find out more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).